Tilray Brands, Inc. - Common Stock (NQ:TLRY)

Earlier this year, the U.S. government announced it would reclassify certain medical cannabis products from Schedule I to Schedule III substances.

Does Marijuana Rescheduling Really Help Tilray's Stock? ↗

November 10, 2026

Tilray Raises Its Guidance for the Year. Is the Stock Finally Headed on the Right Track? ↗

Performance

52-Week Range 83.4% below 52-week high

2.610

2.4852W Low 15.7052W High

1 Week 12.4% below 1-week high

2.501W Low 2.981W High

Tilray Brands, Inc. - Common Stock (TLRY) traded between $2.48 and $15.70 over the past 52 weeks and last traded at $2.61, 83.4% below its 52-week high. Over the past week it ranged between $2.50 and $2.98.

Past 12 Months

-7.1%

-22.3%

-44.2%

-52.2%

-73.1%

-79.8%

1W -$0.20

1M -$0.75

3M -$2.07

6M -$2.85

YTD -$7.11

1Y -$10.29

TLRY was -79.8% over the past year, -52.2% over six months, -73.1% year to date, -7.1% in the last week.

12 Months vs Market

TLRY

-79.8%

DIA

+9.4%

SPY

+11.2%

QQQ

+11.1%

IWM

+15.9%

Over the past 12 months TLRY returned -79.8% versus DIA (Dow) +9.4%, SPY (S&P 500) +11.2%, QQQ (Nasdaq 100) +11.1% and IWM (Russell 2000) +15.9%.

Volume & Liquidity 0.00× 3-mo avg

Today 11,241 3-mo avg 4.2M

5.0M

4.7M

4.2M

4.1M

YTD

4.3M

5.5M

TLRY most recently traded 11,241 shares against a 3-month average daily volume of 4.2M.

More News

November 09, 2026

Which of These 5 Cannabis Stocks Has the Strongest Balance Sheet? ↗

November 08, 2026

Tilray Brands Announces Strategy to Strengthen Canadian Cannabis Operations and Drive Profitable Growth

November 02, 2026

Forget U.S. Rescheduling: Tilray's 71% Growth in Europe Is the Story Investors Are Missing ↗

November 01, 2026

Tilray Just Posted Record Quarterly Revenue of $257 Million. So Why Did Its Cannabis Sales Shrink? ↗

November 01, 2026

Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis ↗

October 30, 2026

Breckenridge Distillery and University of Denver Athletics Release Limited-Edition Whiskey Celebrating Record 11th NCAA Men’s Hockey Championship

October 29, 2026

Tilray Brands Announces Next Phase of Beverage Transformation

October 29, 2026

Down 70% in 2026, Has Tilray's Stock Finally Bottomed Out? ↗

October 27, 2026

Tilray Now Sells More Beer Than Cannabis. Here's Why That Might Be Good News for Investors. ↗

October 25, 2026

Blue Point Brewing Co.’s Legendary Cask Ales Festival Returns to Patchogue with 100+ Limited-Release Brews

October 22, 2026

West Ham United F.C. and BrewDog Unveil Boleyn Brew: A Fan-Created Matchday Beer Made by Hammers, for Hammers

October 21, 2026

This Cannabis Stock Jumped 12% in a Day: The Math Says Be Careful ↗

October 20, 2026

Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026? ↗

October 15, 2026

SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia

October 15, 2026

Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets

October 13, 2026

3 Huge Red Flags From Tilray's Q1 Earnings Report ↗

October 12, 2026

Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026? ↗

October 10, 2026

3 Reasons I'm Still Not Buying Tilray Stock -- Even at Penny-Stock Prices ↗

October 10, 2026

Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform ↗

October 09, 2026

Via MarketBeat

Tilray (TLRY) Q1 2027 Earnings Call Transcript ↗

October 08, 2026

Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit Year-Over-Year Growth Across International Cannabis, Beverage and Pharmaceutical Distribution

Tilray Brands Q1 Earnings Call Highlights ↗

October 08, 2026

Via MarketBeat

October 08, 2026